These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 20352155

  • 1. A comparison of platelet function tests and thromboxane metabolites to evaluate aspirin response in healthy individuals and patients with coronary artery disease.
    Grove EL, Hvas AM, Johnsen HL, Hedegaard SS, Pedersen SB, Mortensen J, Kristensen SD.
    Thromb Haemost; 2010 Jun; 103(6):1245-53. PubMed ID: 20352155
    [Abstract] [Full Text] [Related]

  • 2. A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease.
    Lordkipanidzé M, Pharand C, Schampaert E, Turgeon J, Palisaitis DA, Diodati JG.
    Eur Heart J; 2007 Jul; 28(14):1702-8. PubMed ID: 17569678
    [Abstract] [Full Text] [Related]

  • 3. Aspirin response evaluated by the VerifyNow Aspirin System and light transmission aggregometry.
    Nielsen HL, Kristensen SD, Thygesen SS, Mortensen J, Pedersen SB, Grove EL, Hvas AM.
    Thromb Res; 2008 Jul; 123(2):267-73. PubMed ID: 18499236
    [Abstract] [Full Text] [Related]

  • 4. Antiplatelet effect of aspirin in patients with coronary artery disease.
    Grove EL.
    Dan Med J; 2012 Sep; 59(9):B4506. PubMed ID: 22951204
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study.
    Gurbel PA, Bliden KP, DiChiara J, Newcomer J, Weng W, Neerchal NK, Gesheff T, Chaganti SK, Etherington A, Tantry US.
    Circulation; 2007 Jun 26; 115(25):3156-64. PubMed ID: 17562955
    [Abstract] [Full Text] [Related]

  • 6. Association of cyclooxygenase-1-dependent and -independent platelet function assays with adverse clinical outcomes in aspirin-treated patients presenting for cardiac catheterization.
    Frelinger AL, Li Y, Linden MD, Barnard MR, Fox ML, Christie DJ, Furman MI, Michelson AD.
    Circulation; 2009 Dec 22; 120(25):2586-96. PubMed ID: 19996015
    [Abstract] [Full Text] [Related]

  • 7. Increased platelet sensitivity among individuals with aspirin resistance - platelet aggregation to submaximal concentration of arachidonic acid predicts response to antiplatelet therapy.
    Guthikonda S, Mangalpally K, Vaduganathan M, Patel R, Delao T, Bergeron AL, Dong JF, Lev EI, Kleiman NS.
    Thromb Haemost; 2008 Jul 22; 100(1):83-9. PubMed ID: 18612542
    [Abstract] [Full Text] [Related]

  • 8. Optical platelet aggregation versus thromboxane metabolites in healthy individuals and patients with stable coronary artery disease after low-dose aspirin administration.
    Hedegaard SS, Hvas AM, Grove EL, Refsgaard J, Rocca B, Daví G, Kristensen SD.
    Thromb Res; 2009 May 22; 124(1):96-100. PubMed ID: 19215971
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of aspirin response by Multiplate whole blood aggregometry and light transmission aggregometry.
    Pedersen SB, Grove EL, Nielsen HL, Mortensen J, Kristensen SD, Hvas AM.
    Platelets; 2009 Sep 22; 20(6):415-20. PubMed ID: 19658002
    [Abstract] [Full Text] [Related]

  • 10. Response to aspirin in healthy individuals. Cross-comparison of light transmission aggregometry, VerifyNow system, platelet count drop, thromboelastography (TEG) and urinary 11-dehydrothromboxane B(2).
    Blais N, Pharand C, Lordkipanidzé M, Sia YK, Merhi Y, Diodati JG.
    Thromb Haemost; 2009 Aug 22; 102(2):404-11. PubMed ID: 19652893
    [Abstract] [Full Text] [Related]

  • 11. Comparison of different methods to evaluate the effect of aspirin on platelet function in high-risk patients with ischemic heart disease receiving dual antiplatelet treatment.
    Paniccia R, Antonucci E, Gori AM, Marcucci R, Poli S, Romano E, Valente S, Giglioli C, Fedi S, Gensini GF, Abbate R, Prisco D.
    Am J Clin Pathol; 2007 Jul 22; 128(1):143-9. PubMed ID: 17580282
    [Abstract] [Full Text] [Related]

  • 12. The effect of aspirin dosing on platelet function in diabetic and nondiabetic patients: an analysis from the aspirin-induced platelet effect (ASPECT) study.
    DiChiara J, Bliden KP, Tantry US, Hamed MS, Antonino MJ, Suarez TA, Bailon O, Singla A, Gurbel PA.
    Diabetes; 2007 Dec 22; 56(12):3014-9. PubMed ID: 17848625
    [Abstract] [Full Text] [Related]

  • 13. Reduced blood platelet sensitivity to aspirin in coronary artery disease: are dyslipidaemia and inflammatory states possible factors predisposing to sub-optimal platelet response to aspirin?
    Markuszewski L, Rosiak M, Golanski J, Rysz J, Spychalska M, Watala C.
    Basic Clin Pharmacol Toxicol; 2006 May 22; 98(5):503-9. PubMed ID: 16635110
    [Abstract] [Full Text] [Related]

  • 14. Effects of aspirin and clopidogrel in healthy men measured by platelet aggregation and PFA-100.
    Madsen EH, Schmidt EB, Maurer-Spurej E, Kristensen SR.
    Platelets; 2008 Aug 22; 19(5):335-41. PubMed ID: 18791939
    [Abstract] [Full Text] [Related]

  • 15. Functional and biochemical evaluation of platelet aspirin resistance after coronary artery bypass surgery.
    Zimmermann N, Wenk A, Kim U, Kienzle P, Weber AA, Gams E, Schrör K, Hohlfeld T.
    Circulation; 2003 Aug 05; 108(5):542-7. PubMed ID: 12874188
    [Abstract] [Full Text] [Related]

  • 16. Reduced antiplatelet effect of aspirin is associated with low-grade inflammation in patients with coronary artery disease.
    Larsen SB, Grove EL, Kristensen SD, Hvas AM.
    Thromb Haemost; 2013 May 05; 109(5):920-9. PubMed ID: 23407706
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The risk of false results in the assessment of platelet function in the absence of antiplatelet medication: comparison of the PFA-100, multiplate electrical impedance aggregometry and verify now assays.
    Can MM, Tanboğa IH, Türkyilmaz E, Karabay CY, Akgun T, Koca F, Tokgoz HC, Keles N, Ozkan A, Bezgin T, Ozveren O, Sonmez K, Sağlam M, Ozdemir N, Kaymaz C.
    Thromb Res; 2010 Apr 05; 125(4):e132-7. PubMed ID: 19954823
    [Abstract] [Full Text] [Related]

  • 19. Platelet function measured by VerifyNow identifies generalized high platelet reactivity in aspirin treated patients.
    Dichiara J, Bliden KP, Tantry US, Chaganti SK, Kreutz RP, Gesheff TB, Kreutz Y, Gurbel PA.
    Platelets; 2007 Sep 05; 18(6):414-23. PubMed ID: 17763150
    [Abstract] [Full Text] [Related]

  • 20. Comparison of methods for monitoring residual platelet reactivity after clopidogrel by point-of-care tests on whole blood in high-risk patients.
    Paniccia R, Antonucci E, Maggini N, Miranda M, Gori AM, Marcucci R, Giusti B, Balzi D, Prisco D, Abbate R.
    Thromb Haemost; 2010 Aug 05; 104(2):287-92. PubMed ID: 20458439
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.